Dave Lowrance
2017
In 2017, Dave Lowrance earned a total compensation of $389.1K as Chief Financial Officer & Secretary at Mast Therapeutics.
Compensation breakdown
| Bonus | $88,100 |
|---|---|
| Non-Equity Incentive Plan | $90,750 |
| Salary | $204,271 |
| Other | $6,000 |
| Total | $389,121 |
Lowrance received $204.3K in salary, accounting for 52% of the total pay in 2017.
Lowrance also received $88.1K in bonus, $90.8K in non-equity incentive plan and $6K in other compensation.
Rankings
In 2017, Dave Lowrance's compensation ranked 12,678th out of 14,666 executives tracked by ExecPay. In other words, Lowrance earned more than 13.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,678 out of 14,666 | 14th |
Division Manufacturing | 4,987 out of 5,772 | 14th |
Major group Chemicals And Allied Products | 1,829 out of 2,075 | 12th |
Industry group Drugs | 1,522 out of 1,731 | 12th |
Industry Pharmaceutical Preparations | 1,179 out of 1,333 | 12th |
Source: SEC filing on April 23, 2018.
Lowrance's colleagues
We found six more compensation records of executives who worked with Dave Lowrance at Mast Therapeutics in 2017.
2017
Brian Culley
Mast Therapeutics
Chief Executive Officer
2017
Edwin Parsley
Mast Therapeutics
Former Chief Medical Office & Senior Vice President
2017
Brandi Roberts
Mast Therapeutics
Chief Financial Officer
2017
Robert Neville
Mast Therapeutics
Chief Executive Officer
2017
Taneli Jouhikainen
Mast Therapeutics
Chief Operating Officer
2017
Shana Hood
Mast Therapeutics